Your browser doesn't support javascript.
loading
Sideromimic Modification of Lactivicin Dramatically Increases Potency against Extensively Drug-Resistant Stenotrophomonas maltophilia Clinical Isolates.
Calvopiña, Karina; Umland, Klaus-Daniel; Rydzik, Anna M; Hinchliffe, Philip; Brem, Jürgen; Spencer, James; Schofield, Christopher J; Avison, Matthew B.
Afiliação
  • Calvopiña K; School of Cellular & Molecular Medicine, University of Bristol, Bristol, United Kingdom.
  • Umland KD; Department of Chemistry, University of Oxford, Oxford, United Kingdom.
  • Rydzik AM; Department of Chemistry, University of Oxford, Oxford, United Kingdom.
  • Hinchliffe P; School of Cellular & Molecular Medicine, University of Bristol, Bristol, United Kingdom.
  • Brem J; Department of Chemistry, University of Oxford, Oxford, United Kingdom.
  • Spencer J; School of Cellular & Molecular Medicine, University of Bristol, Bristol, United Kingdom.
  • Schofield CJ; Department of Chemistry, University of Oxford, Oxford, United Kingdom.
  • Avison MB; School of Cellular & Molecular Medicine, University of Bristol, Bristol, United Kingdom matthewb.avison@bris.ac.uk.
Antimicrob Agents Chemother ; 60(7): 4170-5, 2016 07.
Article em En | MEDLINE | ID: mdl-27139464

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Stenotrophomonas maltophilia / Antibacterianos Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Stenotrophomonas maltophilia / Antibacterianos Idioma: En Ano de publicação: 2016 Tipo de documento: Article